Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Factor D: Can blocking immune system pathway stop COVID-19?

COVID UPDATE: Decrease in daily active cases in India

Science and technology help in simplifying tumour testing

Factor D: Can blocking immune system pathway stop COVID-19?
  • BiotechToday
  • World

Factor D: Can blocking immune system pathway stop COVID-19?

bioxone October 13, 2020October 13, 2020

Husna, Amity University Kolkata

As the world is waiting anxiously for a powerful and effective vaccine against covid-19, researchers are also trying to identify how coronavirus attacks the body to stop its devastating impact. One such possible way has been discovered in a recent study by researchers of John Hopkins University. This can be done by blocking a particular protein which enables the virus to turn the immune system against healthy cells of our body.

The protein is known as Factor D which on inhibition will also reduce the deadly inflammatory responses that numerous patients get on being infected. The SARS-CoV-2 virus attaches to a healthy targeted cell of the body to cause infection using the spike proteins present on its surface. The spikes do this by seizing heparan sulphate which is a complex sugar molecule found on cell-surface of lungs, blood vessels and smooth muscles as a result of which Factor H is prevented from using sugar molecule to bind with cells. Factor H regulates the chemical signals that trigger inflammation thus preventing the immune system from harming healthy cells. Without this protection, the lungs, heart, kidneys and other organs will be destroyed by the defence mechanism of our body. The SARS-CoV-2 virus activates a cascading series of biological reactions known as an alternative pathway of complement (APC) when it ties with heparan sulphate which results in inflammation and cell destruction if misread by the immune system.

 So, the research team used normal human blood serum and three sub-units of  SARS-CoV-2 spike protein to find exactly how the virus activates APC, hijacks the immune system and destroys normal cells. They discovered that S1 and S2 sub-units bind virus to heparan sulphate leading to activation of APC cascade and blockage of  Factor H due to which Factor H confers a misdirected immune response. Further, they found that upon blocking another complement protein Factor D, which works immediately upstream within the pathway from Factor H, they were able to stop the destructive chain of events triggered by SARS-CoV-2.

Also read: CAN PHYSICAL EXERCISES IMPROVE HEALTH OF BREAST CANCER SURVIVORS?

Source: https://health.economictimes.indiatimes.com/amp/news/industry/blocking-immune-system-pathway-may-stop-covid-19-johns-hopkins-study/78596131

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged (APC) Alternative pathway of complement cascade series CORONAVIRUS COVID-19 Factor D Factor H heparin sulphate human blood serum immune system inflammation SARS-CoV-2 spike protein VACCINE

3 thoughts on “Factor D: Can blocking immune system pathway stop COVID-19?”

  1. Diwita Roy says:
    October 13, 2020 at 4:41 pm

    Good content 👍👍

    Reply
    1. Husna says:
      October 13, 2020 at 4:42 pm

      Thank you❤️

      Reply
  2. Farah Noor says:
    October 16, 2020 at 9:19 pm

    The description is so clear & precise. MashaAllah. Thankyou Husna! We all are desperately waiting & praying for an effective vaccine to be produced.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Science and technology help in simplifying tumour testing

bioxone October 14, 2020

Camelia Bhattacharyya, Amity University Kolkata We live in a world that needs more fast methods to be used from day-to-day problems to higher or complicated forms of problems; the healthcare system is not excluded from these. Patients are needing immediate treatment after quick testing which mostly depends on the equipment and the techniques used. This […]

Tumour

Related Post

  • BiotechToday
  • World

Alzheimer’s-like dementia due to Covid

BioTech Today June 17, 2021June 16, 2021

Souradip Mallick, National Institute of Technology, Rourkela In the last two decades, various coronavirus diseases have become a major public health issue, starting with the SARS-CoV pandemic in 2002 through 2003, then the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in 2012, and current the COVID-19 pandemic. In all the cases, it has been reported […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Insights on LRRK2, gene behind Parkinson’s disease

bioxone August 7, 2021August 6, 2021

Varuni Ankolekar, Quartesian One of the common neurogenerative disorders noticed in elderly populations is Parkinson’s disease that affects movement. Common symptoms are tremor, rigidity, bradykinesia, and postural instability. Gene behind Parkinson’s disease: Dysfunction of the Leucine-rich repeat kinase 2 (LRRK2) gene on chromosome 12 has proven to be the cause of Parkinson’s disease. LRRK2 is […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Green synthesis of graphite with Carbon dioxide

bioxone January 13, 2021January 13, 2021

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Carbon has always been applied in the fields such as metallurgy, environmental remediation, conversion, automotive industry, etc as it has extensive physicochemical properties. In this report, an efficient approach to making graphite from carbon dioxide at low temperatures in the absence of metal catalysts has been suggested. CO2 is converted […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy